[Federal Register Volume 63, Number 42 (Wednesday, March 4, 1998)]
[Notices]
[Page 10643]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-5575]



[[Page 10643]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting of the National Cancer Institute Frederick Cancer Research and 
Development Center Advisory Committee.
    The open portion of the meeting will be limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the contact person in advance of the meeting.

    Committee Name: Frederick Cancer Research and Development Center 
Advisory Committee.
    Date: April 1, 1998.
    Place: Frederick Cancer Research and Development Center Building 
549, Executive Board Room, Frederick, Maryland 21702-1201.
    Open: 8:30 a.m.-10:00 a.m.
    Agenda: Discussion of administrative matters such as future 
meetings, budget and information items related to the operation of 
the NCI Frederick Cancer Research and Development Center.
    Closed: 10:00 a.m. to Adjournment.
    Agenda/Purpose: Presentations and discussions by the Operations 
and Technical Support Contractor, Science Applications International 
Corporation (SAIC) and Advanced BioScience Laboratories--Basic 
Research Program (ABL-BRP) pertaining to the future direction for 
the Frederick Cancer Research and Development Center.
    Contact Person: David J. Goldstein, Ph.D., Executive Secretary, 
Frederick Cancer Research and Development Center, P.O. Box B, 
Frederick, MD 21702-1201, Telephone: 301-846-1108.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The report 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the programs, 
disclosure of which would constitute a clearly unwarranted invasion 
of personal privacy.

(CATALOG OF FEDERAL DOMESTIC ASSISTANCE PROGRAM NUMBERS: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control.)

    Dated February 24, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-5575 Filed 3-3-98; 8:45 am]
BILLING CODE 4140-01-M